Reestablishment of DCC expression has been shown to suppress tumorigenicity [37, 38], and hypermethylation of its promoter region has been detected not only in breast, gastric, and colon cancers, but also in oral squamous cell carcinoma [39–41]. This evidence concerns the gene DCC and oral cavity squamous cell carcinoma.